|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
The carbohydrate structure of sialyl-Lewis X (SLex) can function as a ligand for E- and P-selectin, which play important roles in mediating the initial interactions of leukocytes with the endothelium in inflammatory responses. In this study we evaluated the effects of inhibiting E- and P-selectin function with the SLex molecule on the inflammatory response in an experimental murine model of hypersensitivity pneumonitis (HP). Antigen exposure induced marked interstitial and especially perivascular and peribronchiolar infiltration with lymphocytes and granuloma formation, in murine lung sensitized with Saccaropolyspora rectivirgula. These pathologic changes were significantly suppressed with SLex ganglioside analogues through a reduction in the numbers of lymphocytes in bronchoalveolar lavage fluid, as evidenced by the lung index and histologic scores indicating the severity of the inflammatory response. Using specific antibodies, we also evaluated the immunohistochemical localization of SLex in mononuclear cells in granulomas, and of E- and P-selectin in vascular endothelium. Our findings suggest that the molecular interaction between SLex, and E- and P-selectin mediates lymphocyte recruitment into the lung parenchyma, which is critical for the inflammatory response in experimental murine models of HP.
| |
INTRODUCTION |
|---|
|
|
|---|
The function of E-selectin and P-selectin in leukocyte rolling, thrombosis, and inflammation, as well as their possible use for therapeutic intervention in reperfusion injury, inflammation, allergy, autoimmunity, and cancer has been described (1). The leukocyte rolling is mediated by the interaction of E- and P-selectin expressed on endothelium with their carbohydrate-bearing physiologic ligand, sialyl-Lewis X (SLex) (10).
Hypersensitivity pneumonitis (HP) is an immunologically
mediated disease that results from repeated exposure to various environmental organic materials (20). Farmer's lung
disease, a common example of HP, is caused by exposure to
Saccharopolyspora rectivirgula (SR), and is characterized by
granuloma formation and interstitial infiltrates consisting primarily of lymphocytes and plasma cells, with occasional neutrophils and eosinophils (20). Previous studies have shown
that T-helper-1 (Th1) lymphocytes play a critical role in the
pathogenesis of HP by producing cytokines such as interferon- (IFN)-
and tumor necrosis factor (TNF)-
(24). Th1 cells
may immigrate into the site of inflammation in HP through
selective recruitment mediated by E-selectin and P-selectin
expressed by endothelial cells (24, 25). Recent reports of in
vivo experiments have suggested that inhibition of the interaction between selectins and their ligands substantially reduces the inflammatory response (26). Therefore, we hypothesized that blocking of the binding between E- and P-selectin
and SLex might suppress the infiltration of Th1 lymphocytes
into lung exposed to antigen. To examine this hypothesis, we
evaluated the effect of SLex ganglioside analogues on the pathologic changes in an experimental murine model of HP.
| |
METHODS |
|---|
|
|
|---|
Antigen and SLex Ganglioside Analogues
SR was obtained from the Osaka Fermentation Institute, Osaka, Japan. SR was cultured in Bennett's agar growth medium at 52° C for 3 d in a shaking incubator. The organism was harvested by centrifugation and washed three times with sterile distilled water, and the cell walls were disrupted with ultrasonication (UR-20; Tomy Seiko, Ltd., Tokyo, Japan) for 25 min. The antigen was kept lyophilized until use.
The structure of SLex ganglioside analogues (27) is shown as follows:
|
|
Animals
Specific pathogen-free male, 6-wk-old C3H/He mice were purchased from Japan Animal Laboratory Inc., Tokyo. They were housed in laminar-flow hoods with high efficiency particular air-filtered air and were given water ad libitum. Mice were housed six to a cage before experimental manipulation and in individual cages thereafter.
Induction of Experimental Hypersensitivity Pneumonitis
Mice were divided into four groups. In Groups 1, 2, and 3 the mice were given 90 µl (2 mg/ml) of SR antigen in saline, intranasally while under light anesthesia with diethyl ether. For controls, physiologic saline was administered instead of SR (Table 1). The materials were applied at the tip of the nose and aspirated involuntarily. This was done for three consecutive days per week for 3 wk. This method was based on previous work done by others (22, 24, 28). We also confirmed in preliminary studies that this was the optimal dose schedule for inducing an inflammatory response in murine lung. In addition, 200 µg particulate SR in normal saline, emulsified in an equal volume of complete Freund's adjuvant (Difco, Detroit, MI), was injected into the base of the tail and two subcutaneous sites (total volume = 0.1 ml) on the first day of the transnasal administration. Seven days later, the mice received 200 µg of SR mixed with an equal volume of incomplete Freund's adjuvant subcutaneously. During the third week, SLex ganglioside analogues were administrated continuously into the skin with a microosmotic pump (Alza Corporation, Palo Alto, CA) at 0.5 µl/h for 7 d to the mice in Group 2 until they were killed. The mice in Group 3 were given 90 µl (2 mg/ml) SLex ganglioside analogues transnasally for five consecutive days. The mice in Groups 2 and 3 were simultaneously given SR transnasally during the third week, as described earlier. Four days after the final administration of SR the mice were killed by exsanguination while under anesthesia with diethyl ether.
|
Bronchoalveolar Lavage
For quantitative cell differential counting in the alveolar epithelial lining fluid, bronchoalveolar lavage (BAL) was performed on the basis of previous work done by others (22, 28). Briefly, after the mice were killed, a 21-gauge catheter was inserted into the trachea. Bronchoalveolar lavage fluid (BALF) samples were obtained by three instillations of 1,200 µl each of physiologic saline. The cells in the BALF were suspended in RPMI-1640 medium and spun down in a cytocentrifuge (Auto Smear CF-120; Sakura, Tokyo, Japan). Cytospin preparations were fixed with 95% ethanol and stained using Diff-Quik staining (Baxter, Inc., McGaw Park, IL). With a microscope, differential counts were made of at least 1,000 cells, using standard morphologic criteria to identify the cells as neutrophils, lymphocytes, eosinophils, or macrophages.
Lung Index
Lungs were removed, trimmed of extraneous tissue, rinsed, and weighed. Lung indices were calculated as follows (22):
|
Histologic Evaluation
Lungs were perfused and fixed in periodate-lysine-paraformaldehyde for 2 h at 4° C and embedded in paraffin or OCT compound (Miles Laboratories, Naperville, IL) for frozen sectioning. The tissue was cut into sections 3 µm thick, stained with hematoxylin and eosin (H&E), and evaluated light microscopically. A histologic score for each lung was determined according to the following criteria: 0 = no lung abnormality; 1 = presence of inflammation and granulomas involving < 10% of the lung parenchyma; 2 = lesions involving 10 to 30% of the lung; 3 = lesions involving 30 to 50% of the lung; and 4 = lesions involving > 50% of the lung (29, 30).
Immunohistochemical Staining
Immunohistochemical staining was performed according to a standard protocol. An immunohistological staining kit using the Histomouse-SP Kit (Zymed Laboratories Inc., CA) was adopted for frozen sections. The biotinylated streptavidin system in a Histofine Kit (Nichirei, Tokyo, Japan) was adopted for staining of paraffin-embedded sections. In brief, the paraffin sections were deparaffinized and treated with 0.3% hydrogen peroxide in methanol for 15 min to block endogenous peroxidase activity. Frozen tissue sections were treated with Peroxo-Block (Zymed) for 45 s. The sources and working dilutions of the antibodies used are listed in Table 2. The sections were then incubated overnight at 4° C with primary antibodies. Aminoethyl carbazole (AEC) or 3'3-diaminobenzidine (DAB) was used as the chromogenic substrate.
|
SLex-Positive T Lymphocytes in Peripheral Blood
Peripheral blood was obtained from the right femoral artery of mice under anesthesia. The number of leukocytes was counted with a hemocytometer. Peripheral blood was smeared on glass slides and stained with Giemsa stain for the analysis of cell types such as polymorphonuclear cells, monocytes, and lymphocytes. SLex-positive T lymphocytes in peripheral blood were identified with antimouse CD3 and antihuman SLex antibodies and their populations were analyzed with a flow cytometry in a fluorescence-activated cell sorter (Becton Dickinson, Inc., Mountain View, CA) with an argon-ion laser.
Statistical Analysis
Statistical analysis was done with the Mann-Whitney U test. Values of p < 0.05 were considered statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Histopathologic Changes in Experimental HP and the Effect of SLex Ganglioside Analogues
Although no inflammatory responses were observed in the lungs of control mice (Figure 2a), in the mice of Group 1 exposed to antigen, the histopathologic examination showed a strong inflammatory response with moderate to marked interstitial and especially perivascular and peribronchiolar infiltration with lymphocytes and granuloma formation (Figure 1b). In the mice in Groups 2 and 3, which were given SLex ganglioside analogues after antigen exposure, lymphocyte infiltration into the lung parenchyma and granuloma formation were less marked than in Group 1 (Figures 1c and 1d). Although the histologic scores were higher than those of the control group, they were also significantly lower than those of Group 1 (histologic scores: control: 0 ± 0.00 [mean ± SD] [n = 9]; Group 1: 3.89 ± 0.11 [n = 9]; Group 2: 2.60 ± 0.49 [n = 6], Group 3: 2.00 ± 0.63 [n = 6]) (Figure 2). In accord with these results, the lung indices of Groups 2 and 3 were significantly lower than that of Group 1 (lung index: control: 1 ± 0.00; Group 1: 1.55 ± 0.38; Group 2: 1.26 ± 0.21; Group 3: 1.27 ± 0.20) (Figure 3).
|
|
|
Analysis of Cell Differential Counts in BALF
In the mice in Group 1, the total cell count in BALF increased (83.1 ± 25.6 × 105; n = 9), over normal control values (7.8 ± 2.2 × 105; n = 9). The predominant cells were lymphocytes (63.25 ± 4.07%), macrophages (20.95 ± 1.02%), and neutrophils (7.6 ± 2.6%), and their percentages differed from those of the control group (lymphocytes: 8.06 ± 0.76%; macrophages: 90.3 ± 0.95%; and neutrophils: 1.01 ± 4.1%). In Groups 2 and 3, the ratio of neutrophils to total numbers of cells was close to that in Group 1. The ratios of lymphocytes to total numbers of cells in Group 2 (31.18 ± 7.00%) and Group 3 (29.16 ± 10.71%) were higher than that of the control group, but were significantly lower than that of Group 1 (Table 3).
|
Accumulated Mononuclear Cells Bearing SLex in Granulomas
Immunohistochemical staining was done with antihuman SLex antibody. In mice of Group 1, the infiltrating mononuclear cells included a large number of lymphocytes, and a substantial number of other cells had the morphology of monocytes or macrophages. A significant percentage of mononuclear cells were positive for SLex in mice of Group 1 (Figure 3). Some neutrophils in the vessels were also positive for SLex (data not shown). In mice given with SLex ganglioside analogues by microosmotic pump (Group 2) and transnasally (Group 3), the number of accumulated mononuclear cells was diminished. Few mononuclear cells positive for SLex were observed (Figures 4b and 4c). The ratios of mononuclear cells expressing SLex to whole cells in granulomas of Group 2 (9.5 ± 9.0%; n = 17) and Group 3 (8.9 ± 8.0%; n = 15) were significantly lower than that of Group 1 (21.7 ± 10.2%; n = 27) (Figure 5).
|
|
SLex-Positive T Lymphocytes in Peripheral Blood
There was no significant change in the numbers of total leukocytes or lymphocytes in the peripheral blood of control mice or mice in Group 1. Furthermore, transnasal treatment with SLex ganglioside analogues (Group 3) did not significantly change these numbers, as shown in Table 4. Nor did the population of SLex-positive T lymphocytes in peripheral blood change significantly among these three groups (Table 4).
|
Expression of E- and P-Selectin
In control mice, the endothelial lining of vessels failed to express E-selectin or P-selectin (Figures 6a and 6b). In contrast, vascular endothelium expressed E- and P-selectin strongly in all mice in Group 1 (Figures 6c and 6d). Strong expression of E- and P-selectin was also observed in Groups 2 and 3 (data not shown).
|
| |
DISCUSSION |
|---|
|
|
|---|
This study evaluated the effects of the inhibition of E- and P-selectin function with SLex ganglioside analogues on the inflammatory response in the lung in experimental HP. We established an experimental model of HP in mice, which showed marked interstitial and especially perivascular and peribronchiolar infiltrates consisting primarily of lymphocytes, in addition to granuloma formation, after antigen exposure. These pathologic changes were significantly suppressed in mice treated with SLex ganglioside analogues, which reduced the infiltration of lymphocytes.
It is well known that E-selectin and P-selectin share the same modular structure, characterized by N-terminal lectin, which is postulated to recognize the carbohydrate ligand SLex (10). It is very important pathophysiologically that the binding of E-selectin and P-selectin to SLex mediates cell-cell interactions in inflammatory diseases (14, 25, 31). In a previous study, SLex ganglioside analogues were shown to contain, between the sugar and the lipophilic moieties, a spacer of various lengths that is necessary for expressing the potent activity of these substances as selectin inhibitors (27). It is known that other analogues of SLex have significant protective effects against lung injury (32). In the present study, significant differences were found in Group 1, which was exposed to antigen, and Groups 2 and 3, which were treated with SLex ganglioside analogues. It is suggested that SLex ganglioside analogues exert an antiinflammatory effect by reducing the numbers of lymphocytes in BALF, and dramatically reduce the lung index and diminish the tissue accumulation of lymphocytes and granuloma formation.
In Groups 2 and 3 in our study, the tissue accumulation of lymphocytes and granuloma formation were diminished, but the inflammatory response was not eliminated completely. There are at least three possible explanations for this. First, the pulmonary inflammation may have occurred before the administration of SLex analogues. Second, since lung leukocyte recruitment relies on adhesion pathways that are partly redundant (33, 34), mononuclear cell migration may not have depended only on the binding of selectins to SLex in our study. Third, the concentration of SLex analogues may not have been sufficient to produce the maximum effect on the migration of leukocytes.
SLex analogues significantly reduced lymphocyte recruitment into the lungs of mice after exposure to SR antigen in our study. In P- and E-selectin-deficient mice, the number of peritoneal neutrophil influxed after thioglycollate injection was suppressed for 8 h compared with that in wild-type mice (35). These results suggested a critical role of binding of SLex to P- and E-selectin in the recruitment of leukocytes to inflammatory sites. However, because the analysis was done only at a single time point in the present study, it is possible that the effect of SLex analogues is limited to delaying the leukocyte recruitment, and that the ultimate magnitude of lung inflammation is not influenced by SLex analogues, because of selectin-independent pathways of leukocyte recruitment.
In the present study, we showed by immunostaining the strong expression of P- and E- selectin in endothelial cells of mice exposed to antigen, suggesting a role for these selectins in the recruitment of mononuclear cells. The strong expression of E- and P-selectin was also observed in Groups 2 and 3 in our study (data not shown). These results suggested that SLex ganglioside analogues did not influence the expression of E- and P-selectin. Both anti-P- and anti-E-selectin antibodies might bind epitopes not affected by the binding of these selectins to SLex analogues, because the immunostaining for E- and P-selectin with the antibodies used in our study was not influenced by the in vitro addition of SLex analogues. In addition, administration of SLex analogues in vivo did not seem to facilitate the shedding of E- or P-selectin.
Th1 cells preferentially secrete IFN-
and TNF-
, which
are thought to activate macrophages and to be responsible for
cell-mediated immune reactions (24, 25). Schuyler and colleagues reported that Th1 CD4+ cell lines could adoptively
transfer experimental HP, which suggested that Th1 cells and
their cytokines might be important in the HP of experimental
murine models (24). Gudmundsson and associates showed
that IFN-
is essential for the pathogenesis of HP by comparing the responses to inhaled antigen of mice lacking the IFN-
gene with that of their normal littermates (22). Austrup and
coworkers reported that Th1 cells but not Th2 cells could efficiently immigrate into inflamed sites, such as sensitized skin or
arthritic joints, and that their recruitment was mediated by
E- and P-selectin (25). In our study, the administration of SLex
ganglioside analogues suppressed the inflammatory response
in our HP model, which included a reduction in the number of
infiltrating lymphocytes, suggesting that SLex ganglioside analogues may inhibit the recruitment of Th1 cells, which play a
critical role in the pathogenesis of HP, although we did not
evaluate Th1 cells in the lung in the present study.
Munro and colleagues reported that from 5% to 15% of circulating T lymphocytes expressed SLex, and that a higher proportion of T cells in inflamed skin were SLex-positive (31). In the present study, there was unexpectedly no significant difference in the number of lymphocytes and in the ratio of SLex-positive T cells in peripheral blood in the control group and the groups of mice given SR alone and SR followed by SLex analyogues given intranasally, as shown in Table 4. Previous studies have shown that leukocytes accumulate in the circulation transiently as a result of inhibition of binding between selectins and SLex (35). With regard to this point, there was a possibility that the changes in the numbers of lymphocytes and the ratios of SLex-positive T cells in peripheral blood might have been subtle on the days when these measures were analyzed, and could not be detected, since antigen exposure was conducted chronically for 3 wk and SLex analogues were administered five times transnasally for 5 d. These results also suggested that at least the decrease in SLex-positive lymphocytes in granulomas in the mice treated with SLex analogues was not directly caused by a decrease in the number of SLex-positive lymphocytes in the peripheral blood. In addition, to eliminate the possibility that the decrease in SLex-positive lymphocytes in granulomas of the mice treated with SLex analogues was due to interference of administered SLex analogues with the binding between SLex and anti- SLex antibody, we performed immunostaining for SLex on lung sections of Group 1 mice to which SLex analogues were added in vitro. The result revealed that in vitro treatment of lung sections with SLex analogues did not inhibit the immunostaining of mononuclear cells for SLex with anti-SLex antibody.
In BALF, the absolute number of lymphocytes in mice exposed to SR was reduced by the administration of SLex analogues. On the other hand, the absolute numbers of macrophages tended to increase in Groups 2 and 3, which were treated with SLex analogues, as compared with Group 1, which was not so treated. From what we know about the effects of SLex analogues on the number of alveolar macrophages, there is no information to explain these findings.
No significant differences were observed between the two different routes of administration of SLex analogues, consisting of transnasal administration and subcutaneous administration with a microosmotic pump. It is possible that SLex analogues are absorbed both through the lining of epithelial cells of the airway and through the blood-circulatory pathway.
In summary, we suggest that the cellular responses in our experimental lung model of HP may have been principally mediated by Th1 lymphocytes recruited from the blood through the interaction between E- and P-selectin and SLex preferentially, and that the lymphocyte-mediated inflammatory responses were significantly suppressed by the competitive inhibitory action of SLex ganglioside analogues.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Hiroshi Inoue, M.D., Ph.D., Third Department of Internal Medicine, Iwate Medical University, School of Medicine, 19-1 Uchimaru, Morioka, Japan. E-mail: hinoue{at}Iwate-med.ac.jp
(Received in original form December 2, 1998 and in revised form August 9, 1999).
Acknowledgments: Supported by the Ministry of Education, Science and Culture, Japan.
| |
References |
|---|
|
|
|---|
1. Yednock, T. A., and S. D. Rosen. 1989. Lymphocyte homing. Adv. Immunol. 44: 313-378 [Medline].
2. Stoolman, L. M.. 1989. Adhesion molecules controlling lymphocyte migration. Cell 56: 907-910 [Medline].
3. Picker, L. J., and E. C. Butcher. 1992. Physiological and molecular mechanisms of lymphocyte homing. Annu. Rev. Immunol. 10: 561-591 [Medline].
4.
Lasky, L. A..
1992.
Selectin: interpreters of cell-specific carbohydrate information during inflammation.
Science
258:
964-969
5. Rosen, S. D.. 1993. Cell surface lectin in the immune system. Semin. Immunol. 5: 237-247 [Medline].
6. McEver, R. P.. 1994. Selectins. Curr. Opin. Immunol. 6: 75-84 [Medline].
7.
Lefer, A. M.,
A. S. Weyrich, and
M. Buerke.
1994.
Role of selectin, a
new family of adhesion molecules, in ischaemia-reperfusion injury.
Cardiovasc. Res.
28:
289-294
8. Bevilacqua, M. P., and M. N. Richard. 1993. Selectins. J. Clin. Invest. 91: 379-387 .
9. Ley, K.. 1996. Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc. Res. 32: 733-742 [Medline].
10.
Varki, A..
1994.
Selectin ligands.
Proc. Natl. Acad. Sci. U.S.A.
91:
7390-7397
11.
Norman, K. E.,
G. P. Anderson,
H. C. Kolb,
K. Ley, and
B. Ernst.
1998.
Sialyl LewisX (SLex) and an SLex Mimetic, CGP69669A, disrupt
E-selectin-dependent leukocyte rolling in vivo.
Blood
91:
475-483
12.
McEver, R. P.,
K. L. Moore, and
R. D. Cummings.
1995.
Leukocyte trafficking mediated by selectin-carbohydrate interactions.
J. Biol. Chem.
270:
11025-11028
13.
Foxall, C.,
S. R. Watson,
D. Dowbenko,
C. Fennie,
L.A. Lasky,
M. Kiso,
A. Hasegawa,
D. Asa, and
B. K. Brandley.
1992.
The three members
of the selectin receptor family recognize a common carbohydrate
epitope, the sialyl-LewisX oligosaccharide.
J. Cell Biol.
117:
895-902
14.
Philips, M. L.,
E. Nudelman,
F. C. A. Gaeta,
M. Perez,
A. K. Singhal,
S. Hakomori, and
J. C. Paulson.
1990.
ELMA-1 mediates cell adhesion
by recognition of a carbohydrate ligand, sialyl-Lex.
Science
250:
1130-1132
15.
Kansas, G. S..
1996.
Selectins and their ligands: current concepts and controversies.
Blood
88:
3259-3287
16. Nelson, R. M., A. Venot, and M. P. Bevilacqua. 1995. Carbohydrate-protein interaction in vascular biology. Annu. Rev. Cell Dev. Biol. 11: 601-631 . [Medline]
17.
Berg, E. L.,
M. K. Robinson,
O. Mansson,
E. C. Butcher, and
E. C. Magnani.
1991.
A carbohydrate domain common to both sialyl-Lea and
Sialyl-Lex is recognized by the endothelial cell leukocyte adhesion
molecule ELAM-1.
J. Biol. Chem.
266:
14869-14872
18. Kolbinger, F., J. T. Patton, G. Geisenhoff, A. Aenis, X. H. Li, and A. G. Katopodis. 1996. The carbohydrate-recognition domain of E-selectin is sufficient for ligand binding under both static and flow conditions. Biochemistry 35: 6385-6392 [Medline].
19.
Kansas, G. S.,
K. B. Saunders,
K. Ley,
A. Zakrzewicz,
R. M. Gibson,
B. C. Furie,
B. Furie, and
T. F. Tedder.
1994.
A role for the epidermal
growth factor-like domain of P-selectin in ligand recognition and cell
adhesion.
J. Cell Biol.
124:
609-618
20. Schuyler, M., K. Gott, and P. Haley. 1991. Experimental murine hypersensitivity pneumonitis. Cell. Immunol. 136: 303-317 [Medline].
21. Salvaggio, J. E.. 1997. Extrinsic allergic alveolitis (hypersensitivity pneumonitis): past, present and future. Clin. Exp. Allergy 27(Suppl.): 18-25 .
22.
Gudmundsson, G., and
G. W. Hunninghake.
1997.
Interferon-
is necessary for the expression of hypersensitivity pneumonitis.
J. Clin Invest.
99:
2386-2390
[Medline].
23. Kurup, V. P., and N. S. Agre. 1983. Transfer of Micropolyspora rectivirgula (Krassilnikov and Agre, 1964) Lechevalier, Lechevalier, and Becker 1966 to Faenia gen. nov. Int. J. Syst. Bacteriol. 33: 663-665 .
24. Schuyler, M., K. Gott, A. Cherne, and B. Edwards. 1997. Th1 CD4+ cells adoptively transfer experimental hypersensitivity pneumonitis. Cell. Immunol. 177: 169-175 [Medline].
25. Austrup, F., D. Vestweber, E. Borges, M. Lohning, R. Brauer, U. Herz, H. Renz, R. Hallmann, A. Scheffold, A. Radbruch, and A. Hamann. 1997. P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 385: 81-83 [Medline].
26. Lowe, J. B., and P. A. Ward. 1997. Therapeutic inhibition of carbohydrate-protein interaction in vivo. J. Clin. Invest. 11(Suppl. 100):S47-S51.
27. Adachi, K., Y. Yamada, H. Wada, A. Kameyama, H. Ishida, and M. Kisob. 1998. Synthesis of sialyl-Lewis X ganglioside analogues containing a variety length of spacer between sugar and lipophilic moiety. J. Carbohydr. Chem. 17: 595-607 .
28. Takizawa, H., M. Suko, N. Kobayashi, S. Shoji, K. Ohta, M. Nogami, H. Okudaira, T. Miyamoto, and J. Shiga. 1988. Experimental hypersensitivity pneumonitis in the mouse: histologic and immunologic feature and their modulation with cyclosporin A. J. Allergy Clin. Immunol. 81: 391-400 [Medline].
29. Takizawa, H., K. Ohta, T. Horiuchi, N. Suzuki, T. Ueda, M. Yamaguchi, N. Yamashita, A. Ishii, and H. Okudaira. 1992. Hypersensitivity pneumonitis in athymic nude mice: additional evidence of T cell dependency. Am. Rev. Respir. Dis. 146: 479-484 [Medline].
30. Ito, K., K. Yamasaki, K. Onoue, and M. Ando. 1993. Experimental hypersensitivity pneumonitis in mice induced by Trichosporon cutaneum: histologic and immunologic features and effect of in vivo depletion of T cell subsets. Exp. Lung Res. 19: 631-652 [Medline].
31. Munro, J. M., S. K. Lo, C. Corless, M. J. Robertson, N. C. Lee, R. L. Barnhill, D. S. Weinberg, and M. P. Bevilacqua. 1992. Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues. Am. J. Pathol. 141: 1397-1408 [Abstract].
32. Mulligan, M. S., J. C. Paulson, S. De Frees, Z. L. Zheng, J. B. Lowe, and P. A. Ward. 1992. Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature 364: 149-151 .
33. Chin, J. E., C. A. Hatfield, G. E. Winterrowd, J. R. Brashler, S. L. Vonderfecht, S. F. Fidler, R. L. Griffin, K. P. Kolbasa, R. F. Krzesicki, L. M. Sly, N. D. Staite, and I. M. Richards. 1997. Airway recruitment of leukocytes in mice is dependent on alpha-4-integrins and vascular cell adhesion molecule-1. Am. J. Physiol. 272(2, Pt. 1):L219-229.
34.
Wolber, F. M.,
J. L. Curtis,
P. Maly,
R. J. Kelly,
P. Smith,
T. A. Yednock,
J. B. Lowe, and
L. M. Stoolman.
1998.
Endothelial selectins and
alpha4 integrins regulate independent pathways of T lymphocyte recruitment in the pulmonary immune response.
J. Immunol.
161:
4396-4403
35. Frenette, P. S., T. N. Mayadas, H. Rayburn, R. O. Hynes, and D. D. Wagner. 1996. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 84: 563-574 [Medline].
This article has been cited by other articles:
![]() |
J. N. Fink, H. G. Ortega, H. Y. Reynolds, Y. F. Cormier, L. L. Fan, T. J. Franks, K. Kreiss, S. Kunkel, D. Lynch, S. Quirce, et al. Needs and Opportunities for Research in Hypersensitivity Pneumonitis Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 792 - 798. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Koarai, M. Ichinose, S. Ishigaki-Suzuki, S. Yamagata, H. Sugiura, E. Sakurai, Y. Makabe-Kobayashi, A. Kuramasu, T. Watanabe, K. Shirato, et al. Disruption of L-Histidine Decarboxylase Reduces Airway Eosinophilia but not Hyperresponsiveness Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 758 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Curtis, J. Sonstein, R. A. Craig, J. C. Todt, R. N. Knibbs, T. Polak, D. C. Bullard, and L. M. Stoolman3 Subset-Specific Reductions in Lung Lymphocyte Accumulation Following Intratracheal Antigen Challenge in Endothelial Selectin-Deficient Mice J. Immunol., September 1, 2002; 169(5): 2570 - 2579. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Navarro, F. Mendoza, L. Barrera, L. Segura-Valdez, M. Gaxiola, I. Paramo, and M. Selman Up-regulation of L-Selectin and E-Selectin in Hypersensitivity Pneumonitis Chest, February 1, 2002; 121(2): 354 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Tuberculosis, Lung Infections, and Interstitial Lung Disease in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1774 - 1788. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |